A Phase 1, Randomized, Placebo Controlled, Crossover Study to Evaluate the Efficacy of GSK1440115 After a Single Oral Dose in Patients With Asthma.

Trial Profile

A Phase 1, Randomized, Placebo Controlled, Crossover Study to Evaluate the Efficacy of GSK1440115 After a Single Oral Dose in Patients With Asthma.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 May 2013

At a glance

  • Drugs GSK 1440115 (Primary)
  • Indications Asthma
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
    • 01 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top